ARVO 2021: Investigational Agent Containing Selenium Sulfide Shows Promise for Meibomian Gland Dysfunction
If findings are confirmed, it could be the first effective pharmacotherapy specifically for this indication
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.